96 results
8-K
EX-10.2
LSTA
Lisata Therapeutics Inc
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
notice of its election to do so. After delivery of such notice and the retention of counsel reasonably acceptable to Indemnitee, the Company shall
8-K
EX-2.1
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
Caladrius to comply with the terms of any employment, severance, retention, change of control, or similar agreement specified on Section 3.17(c